Phase 1/2 Safety and Antitumor Activity of Nivolumab in Patients with Advanced Hepatocellular Carcinoma (HCC): CA209-040
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

其它資訊
著者EI-KHOUEIRY A, MELERO I, CROCENZI T, WELLING T, YAU T, YEO Winnie, CHOPRA A, GROSSO J, LANG L, ANDERSON J, CRUZ C, SANGRO B
會議名稱51st Annual Meeting of American Society Of Clinical Oncology
會議國家/地區美國
會議論文集題名51st Annual Meeting of American Society Of Clinical Oncology
詳細描述organized by American Society of Clinical Oncology meeting,
出版年份2015
月份6
出版地United States of America
語言英式英語
關鍵詞HCC

上次更新時間 2018-20-01 於 14:01